Insight

Manel Esteller: Epigenetic Hallmarks in Cancer in Cancer Discovery

Manel Esteller/X

Oct 8, 2024, 15:49

Manel Esteller: Epigenetic Hallmarks in Cancer in Cancer Discovery

Manel Esteller, Director of the Josep Carreras Leukaemia Research Institute, shared a post on X:

“Epigenetic Hallmarks in Cancer in Cancer Discovery, AACR Promoter CpG island hypermethylation-associated silencing targets all classical and new dimension hallmarks of cancer by Weinberg MIT, Whitehead Institute and Hanahan, Ludwig Cancer, EPFL.”

Manel Esteller

The Epigenetic Hallmarks of Cancer

Source: Manel Esteller, Mark A. Dawson, Cigall Kadoch, Feyruz V. Rassool, Peter A. Jones, Stephen B. Baylin

Manel Esteller

AACR cancer Cancer Discovery Cigall Kadoch EPFL Feyruz V. Rassool Hanahan Josep Carreras Leukaemia Research Institute Ludwig Cancer Manel Esteller Mark A. Dawson OncoDaily Oncology Peter A. Jones Stephen B. Baylin Weinberg MIT Whitehead Institute

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer

Black History Month 2025: Honoring Contributions to Oncology